Why is "Metastatic" trending?
Latest news, Wikipedia summary, and trend analysis.
Trend Analysis
- Ranking position: #
- Date: 2026-07-19 09:41:28
This topic has appeared in the trending rankings 1 time(s) in the past year. While it does not trend frequently, its appearance suggests a renewed or concentrated surge of public interest.
Based on Wikipedia pageviews and search interest, this topic gained significant attention on the selected date.
Trend Insight
Metastatic entered the ranking for the first time today at position #. This is its highest position ever recorded.
Trend History
This topic has appeared in the English Wikipedia rankings 1 time. It first appeared on 2026-07-19 and was most recently seen on 2026-07-19.
Wikipedia Overview
Metastasis is the spread of a pathogenic agent from an initial or primary site to a different or secondary site within the host's body; the term is typically used when referring to metastasis by a cancerous tumor. The newly pathological sites, then, are metastases (mets). It is generally distinguished from cancer invasion, which is the direct extension and penetration by cancer cells into neighboring tissues.
Read more on Wikipedia →Related Topics
Trending Topic Today
Search Interest Perspective
-
FDA approves new breast cancer drug based on VIKTORIA-1 study results - Fred Hutchinson Cancer Center
-
China’s NMPA Approves Iza-Bren for Pretreated Recurrent/Metastatic ESCC - OncLive
-
Evolving patterns of co-mutations from tumor initiation to metastatic progression - Nature
-
Clinical Scenario - De Novo HER2-Positive Metastatic Breast Cancer - CancerNetwork
-
FDA Grants Traditional Approval to Selpercatinib for Locally Advanced or Metastatic RET Fusion–Positive Solid Tumors - The ASCO Post
-
FDA Approves Gedatolisib for HR+/HER2- Metastatic Breast Cancer - Oncology Nursing News
-
Kunal Jobanputra: Happy to Share Our JCO Global Oncology Study on Metastatic NSGCT - Oncodaily
-
Quality-of-Life Considerations During Treatment for Metastatic EGFR-Positive NSCLC - Cure Today
-
Most of Congress backs this bill to support breast cancer patients. Why isn’t it law? - The Hill
-
Managing Fatigue, Function, and Treatment Burden in Metastatic Hormone-Sensitive Prostate Cancer - Catherine Handy Marshall - UroToday
-
Caris Life Sciences Expands Precision Oncology in Metastatic Prostate Cancer with PTEN IHC Testing - PR Newswire
-
FDA Approves Gedatolisib Plus Fulvestrant ± Palbociclib for Hormone Receptor–Positive, HER2-Negative, Locally Advanced/Metastatic Breast Cancer - OncLive
-
OPTIM: a randomized phase II trial of nivolumab followed by nivolumab-ipilimumab or docetaxel at progression in recurrent/metastatic squamous cell carcinoma of the head and neck (OPTIM; AIO-KHT-0117) - Nature
-
Frontline and Subsequent Treatment Planning for Metastatic EGFR-Positive NSCLC - Cure Today
-
Patient-Reported Outcomes and Future Research Directions in HER2-Positive Metastatic Breast Cancer - CancerNetwork
-
GLP-1 Receptor Agonists May Reduce Metastatic Progression in Certain Obesity-Related Cancers - The ASCO Post
-
Dr. Choudhury on the Importance of Volume Status in Metastatic Prostate Cancer - OncLive
-
Agenus Discontinues Phase 3 BATTMAN Trial in Metastatic MSS Colorectal Cancer - CancerNetwork
-
HR-Positive/HER2-Negative Metastatic Breast Cancer: Integrating Oral SERDs Into Treatment Sequencing - OncLive
-
HR-Positive/HER2-Negative Metastatic Breast Cancer: ESR1 Mutation Monitoring and the Evolving Role of Oral SERDs - OncLive
-
Investigator-Assessed PFS May Be Comparable to BICR in HR+/HER2− Metastatic Breast Cancer Trials - Oncodaily
-
CagA promotes gastric cancer stemness and metastasis via DNMT1-mediated epigenetic silencing of BEX1 - Nature
-
Metastatic Leiomyosarcoma Presenting as a... : American Journal of Gastroenterology - Lippincott Home
-
Olubukola Ayodele: Changing the Story of Metastatic Breast Cancer Together - Oncodaily
-
Elraglusib and chemotherapy in metastatic pancreatic ductal adenocarcinoma: a randomized controlled phase 2 trial - Nature
-
GLP-1 Agonists Associated With Major Reduction in Metastatic Cancer Progression - Targeted Oncology
-
EMA fast tracks review of a medicine for metastatic pancreatic cancer - European Medicines Agency (EMA)
-
Oligometastatic prostate cancer — bridging the gap between localized and metastatic disease - Nature
-
Evolutionary characterization of lung cancer metastasis - Nature
-
Type I interferons induced upon respiratory viral infection impair lung metastatic initiation - PNAS
-
A glucocorticoid–FAS axis controls immune evasion during metastatic seeding - Nature
-
FDA Approves Metastatic Breast Cancer Drug Enhertu for Early-Stage Disease - Breast Cancer Research Foundation | BCRF
-
Matthew Kurian: FDA Approves Gedatolisib with Fulvestrant for HR+/HER2− Metastatic Breast Cancer - Oncodaily
-
Advanced age increases cancer-specific mortality in bone-only metastatic prostate cancer: a SEER analysis - Nature
-
A New Clinical Trial for Metastatic Breast Cancer Opens - UNC Health
-
Clinical and Cost Impact of Cabazitaxel Versus Lutetium-177 Vipivotide Tetraxetan (Lu-PSMA) for Patients With Metastatic Castration-Resistant Prostate Cancer (mCRPC) - OncLive
-
The potential directing role of chemokines for specific metastatic sites in breast cancer - Nature
-
Gotistobart or docetaxel in metastatic squamous non-small cell lung cancer: stage 1 of the randomized phase 3 PRESERVE-003 trial - Nature
-
Understanding the Sequencing Decisions in mCRPC After Progression on ADT/ARPI - Targeted Oncology
-
Leptomeningeal metastatic cancer cells induce a permissive choroid plexus vasculature through extracellular-vesicle-derived 5-HIAA signaling - Nature
-
When Imaging and Biopsy Mislead: Recurrent Triple-Negative Breast Cancer Mimicking Fat Necrosis - Cureus
-
Bile acid buildup linked to aggressive breast cancer progression - News-Medical
-
Prostate cancer cells converge to an inflammatory-like state upon metastatic dissemination - Nature
-
FDA Approves Revtorpyk for Advanced HR-Positive, HER2-Negative Breast Cancer - Cure Today
-
Concurrent Complete Spinal Cord Syndrome and Sixth Cranial Nerve Palsy in Advanced Adenoid Cystic Carcinoma: A Case Report and Literature Review - Cureus
-
Your next steps if breast cancer becomes metastatic - Roswell Park Comprehensive Cancer Center
-
First Patients Dosed With TLX597-Tx in Trial for mHSPC - Targeted Oncology
-
Hijacking the bone niche: mechanistic insights into bone metastasis in breast cancer - Nature
-
Yale Launches Innovative Clinical Trial for Metastatic Bladder Cancer - Yale School of Medicine
-
Tumor Microenvironment: Why It Matters for Cancer Immunotherapy - Oncodaily
-
Daraxonrasib Extends Median Survival in Previously Treated Pancreatic Cancer - The ASCO Post
-
Experimental Drug Doubles Median Survival in Patients With Metastatic Pancreatic Cancer - Harvard Medical School
-
FDA Fully Approves Selpercatinib (Retevmo) for RET-Positive Tumors - Oncology News Central
-
Metastatic male breast cancer: Joe’s story - Roswell Park Comprehensive Cancer Center
-
ULK1 promotes metastatic progression in experimental models of epithelial ovarian cancer | Oncogene - Nature
-
Metastatic Breast Cancer Research: An Area of Focus for BCRF - Breast Cancer Research Foundation | BCRF
-
Metastatic Breast Cancer: Current and Emerging Treatments - Medscape
-
Multi-omics evaluation of cell lines as models for metastatic prostate cancer - Nature
-
Amivantamab in Chemorefractory RAS/BRAF Wild-Type Metastatic Colorectal Cancer - The ASCO Post
-
Organ-specific pre-metastatic and metastatic niches in colorectal cancer: “discrepancy in response to immune checkpoint inhibitors in liver and lung metastasis” - Frontiers
-
A Case of Gastrointestinal Krukenberg Tumor Initially Suspected as Primary Ovarian Cancer and the Implications for Management - Cureus
-
An Unusual Presentation of Leiomyosarcoma Mimicking Parasitic Fibroids: A Diagnostic Dilemma - Cureus
-
Integrative analyses of metastatic cancer transcriptome reveal clinically distinct cellular States and ecosystems - Nature
-
First RAS Inhibitor Extends Survival in Previously Treated Metastatic Pancreatic Adenocarcinoma: What You Need to Know - Pancreatic Cancer Action Network
-
Metastatic Breast Cancer Retreat - Northside Hospital
-
Clinical Trial: Proton Flash Radiotherapy Helps Reduce Patient Pain from Thoracic Bone Metastases - Imaging Technology News
-
Personalizing therapies over the course of hormone receptor-positive/HER2-negative metastatic breast cancer - Wiley & Sons
-
5 Takeaways from BCRF’s Webinar on Advancements in Metastatic Breast Cancer Care - Breast Cancer Research Foundation | BCRF
-
A Mechanophenotyping chip for high-throughput detection of metastatic bacteria-infected circulating tumor cells - Nature
-
Celcuity Announces FDA Approval of REVTORPYK™ (gedatolisib) - GlobeNewswire
-
Evolving Strategies in the Management of HR+, HER2– Metastatic Breast Cancer - OncLive
-
FDA Grants Traditional Approval To Selpercatinib For Locally Advanced Or Metastatic Solid Tumors - TradingView
-
BriaCell Opens First Canadian Site - Sunnybrook - for Pivotal Phase 3 Trial in Metastatic Breast Cancer - Investing News Network
-
Can ctDNA Predict Metastatic Risk in Bladder Cancer? - Oncology News Central
-
Advancing Immunotherapy in Metastatic Cancers: Identifying Mechanisms, Targeting Sanctuaries - ASCO Daily News
-
RASolute-302 Introduces a Potential New Treatment Paradigm in Metastatic PDAC Using Oncogenic RAS Targeting - ASCO Daily News
-
Metastatic melanoma survivor trusts UT MD Anderson’s expertise and research - UT MD Anderson
-
Immune Escape Mechanism in Metastatic Breast Cancer Identified - Inside Precision Medicine
-
New platform aims to better predict metastatic cancer risk - News at IU
-
Cellular states associated with metastatic organotropism and survival in patients with pancreatic ductal adenocarcinoma - Nature
-
NCS First in Region With New Pancreatic Cancer Drug - Midwest Medical Edition
-
Inferring cancer type-specific patterns of metastatic spread using Metient - Nature
-
Nutrient requirements of organ-specific metastasis in breast cancer - Nature
-
Darovasertib + Crizotinib Shows PFS Benefit in First-Line HLA-A2–Negative Metastatic Uveal Melanoma - ASCO Daily News
-
A Framework for MRI Characterization of Intracranial Metastatic Disease - RSNA Journals
-
UTSW, InterAct partner on novel gene therapy for metastatic cancer: Newsroom - UT Southwestern
-
Parag Roy: A New Targeted Option for PIK3CA Wild-Type HR+/HER2- Metastatic Breast Cancer - Oncodaily
-
Using Real-World Data to Improve HRR Testing Rates Among Patients With mCRPC - HMP Global Learning Network
-
Targeting orthotopic and metastatic pancreatic cancer with allogeneic stem cell–engineered mesothelin-redirected CAR-NKT cells - PNAS
-
Bladder Cancer Therapy Enfortumab Vedotin (Padcev®) Provides Lasting Benefits, Long-Term Data Confirms - Memorial Sloan Kettering Cancer Center
-
Editorial: Cancer metastases: mechanisms of tumor dissemination, formation of metastatic niche and anti-metastatic therapy - Frontiers
-
The CXCL12-CXCR4 axis in colorectal cancer: immune regulation, metastatic progression, and therapeutic implications - Frontiers
-
ASCO GU 2026: Survival Outcomes in Metastatic Bladder Cancer Patients in the United States - UroToday
-
Paolo Tarantino, MD, PhD, on HER2-Positive Metastatic Breast Cancer: Overall Survival by Genomic Profile - The ASCO Post
-
Truqap recommended by FDA Advisory Committee for PTEN-deficient metastatic hormone-sensitive prostate cancer - AstraZeneca
-
High risk of metastatic recurrence among young cancer patients - UC Davis Health
-
Recent Rates of Systemic Treatment for Metastatic NSCLC in Older Adults - The ASCO Post
-
Agenus Reports Landmark BOT+BAL Data Showing 33% Three-Year Overall Survival in Refractory MSS Metastatic Colorectal Cancer Without Active Liver Metastases at ESMO GI 2026 - 뉴스와이어
-
Emerging paradigms in the study of brain metastases - Science | AAAS
-
Trastuzumab Deruxtecan plus Pertuzumab for HER2-Positive Metastatic Breast Cancer - The New England Journal of Medicine
Why This Topic Is Trending
This topic has recently gained attention due to increased public interest. Search activity and Wikipedia pageviews suggest growing global engagement.
Search Interest & Related Topics
Search interest data over the past 12 months indicates that this topic periodically attracts global attention. Sudden spikes often correlate with major news events, public statements, or geopolitical developments.